Global Managed Access Program Cohort for Ligelizumab in CSU
NCT04903613
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Chronic Spontaneous Urticaria
Interventions
DRUG:
Ligelizumab
Sponsor
Novartis Pharmaceuticals